Related Experiment Video
Updated: Feb 10, 2026

Visualization of Endoplasmic Reticulum Localized mRNAs in Mammalian Cells
Published on: December 17, 2012
Met receptor inhibitor SU11274 localizes in the endoplasmic reticulum
Edwin J Wiest1, Heather Jensen Smith2, Michael A Hollingsworth1
1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA; Eppley Institute, Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
Abstract:
We discovered that SU11274, a class I c-Met inhibitor, fluoresces when excited by 488 nm laser light and showed rapid specific accumulation in distinct subcellular compartments. Given that SU11274 reduces cancer cell viability, we exploited these newly identified spectral properties to determine SU11274 intracellular distribution and accumulation in human pancreatic cancer cells. The aim of the studies reported here was to identify organelle(s) to which SU11274 is trafficked. We conclude that SU11274 rapidly and predominantly accumulates in the endoplasmic reticulum.
Insights
SU11274, a c-Met inhibitor, fluoresces and accumulates in specific cell parts. This study found it primarily targets the endoplasmic reticulum in human pancreatic cancer cells.
Area of Science:
- Cell Biology
- Cancer Research
- Pharmacology
Background:
- SU11274 is a known class I c-Met inhibitor with anti-cancer properties.
- The drug exhibits unique fluorescent properties when exposed to 488 nm laser light.
- Understanding drug localization is crucial for cancer therapy optimization.
Purpose of the Study:
- To investigate the subcellular localization and accumulation patterns of SU11274.
- To identify specific organelles targeted by SU11274 in human pancreatic cancer cells.
- To leverage the fluorescent properties of SU11274 for intracellular tracking.
Main Methods:
- Utilizing the intrinsic fluorescence of SU11274.
- Employing laser excitation at 488 nm.
- Microscopy techniques to observe intracellular distribution in pancreatic cancer cells.
Main Results:
- SU11274 demonstrated rapid and specific accumulation within cells.
- The drug's fluorescent properties facilitated visualization of its intracellular trafficking.
- Predominant accumulation of SU11274 was observed in the endoplasmic reticulum.
Conclusions:
- SU11274 is rapidly trafficked and predominantly accumulates in the endoplasmic reticulum.
- The endoplasmic reticulum is a key organelle for SU11274 localization in pancreatic cancer.
- These findings provide insights into the pharmacodynamics of SU11274.
Related Concept Videos
Endoplasmic Reticulum
The Endoplasmic Reticulum
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Directing Proteins to the Rough Endoplasmic Reticulum
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

